Evidence map›Paper›PMID 39051631›Full record

ArticleAnalytical chemistry2024

Direct Enantiomer Differentiation of Drugs and Drug-Like Compounds via Noncovalent Copper-Amino Acid Complexation and Ion Mobility-Mass Spectrometry.

Benjamin K Blakley, Emanuel Zlibut, Rashi M Gupta, Jody C May, John A McLean

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Chiral Carbohydrate Adducts are Effective for Enantiomeric Ion Mobility Separations.Journal of the American Society for Mass Spectrometry · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin K BlakleyDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.ORCID 0009-0003-3263-5289
Emanuel ZlibutDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.ORCID 0000-0002-3171-1513
Rashi M GuptaDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.ORCID 0009-0006-2983-4852
Jody C MayDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.ORCID 0000-0003-4871-5024
John A McLeanDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee 37235-1822, United States.ORCID 0000-0001-8918-6419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug enantiomers can possess vastly different pharmacological properties, yet they are identical in their chemical composition and structural connectivity. Thus, resolving enantiomers poses a great challenge in the field of separation science. Enantiomer separations necessitate interaction of the analyte with a chiral environment─in mass spectrometry-based analysis, a common approach is through a three-point interaction with a chiral selector commonly introduced during sample preparation. In select cases, the structural difference imparted through noncovalent complexation results in enantiomer-specific structural differences, facilitating measurement using a structurally selective analytical technique such as ion mobility-mass spectrometry (IM-MS). In this work, we investigate the direct IM-MS differentiation of chiral drug compounds using mononuclear copper complexes incorporating an amino acid chiral selector. A panel of 20 chiral drugs and drug-like compounds were investigated for separation, and four l-amino acids (l-histidine, l-tryptophan, l-proline, and l-tyrosine) were evaluated as chiral selectors (CS) to provide the chiral environment necessary for differentiation. Enantiomer differentiation was achieved for four chiral molecule pairs (

Indexed as

Amino AcidsCopperIon Mobility SpectrometryCoordination ComplexesMass SpectrometryMolecular StructurePharmaceutical PreparationsStereoisomerismAmino AcidsCoordination ComplexesCopperPharmaceutical Preparations

Identifiers

PMID39051631
PMCPMC11307251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.